Industry Research Reports

Home > Reports > Medical Care > Global Tuberculosis (TB) Diagnostics Market Research Report 2025

Global Tuberculosis (TB) Diagnostics Market Research Report 2025

Industry: Medical Care

Published Date: 2025-06-22

Pages: 74 Pages

Report ld: 3470979

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Tuberculosis (TB) Diagnostics Market Size(US$)

CAGR 2025-2031

4.5%

Market Size,2031

USD 4,149

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 3,186 million

Market Forecast in 2031(Value)

US$ 4,149 million

CAGR

4.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Tuberculosis (TB) Diagnostics was valued at US$ 3070 million in the year 2024 and is projected to reach a revised size of US$ 4149 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

The global TB diagnostics market is being propelled by the urgent need to improve disease detection and control in response to the persistent burden of tuberculosis, particularly in high-prevalence regions. Efforts to reach WHO’s End TB goals have elevated funding for TB programs, driving the rollout of advanced diagnostic tools like molecular assays , X‑ray based screening solutions with AI assistance, and point-of-care tests. Furthermore, increasing integration of TB screening within broader healthcare initiatives—such as universal healthcare coverage and integrated respiratory disease programs—has expanded testing capacity. The push to screen high-risk populations, including people living with HIV, healthcare workers, migrants, and prison inmates, has also increased demand for rapid, accurate, and decentralized diagnostic methods capable of delivering same-day results and guiding treatment decisions.

Despite significant advancements in TB diagnostics, substantial barriers continue to hinder market expansion. One major challenge is inconsistent access to cutting-edge diagnostic tools in low- and middle-income countries, where infrastructure remains limited and centralized laboratory systems struggle to support widespread deployment. Additionally, the cost of advanced molecular and imaging technologies remains a deterrent, particularly when factoring in expenses for equipment maintenance, consumables, and the specialized training required for healthcare personnel. The regulatory and logistical complexities involved in distributing diagnostic platforms—especially in remote rural areas—also slow down adoption. Finally, the co-existence of disparate diagnostic algorithms across countries, combined with variable healthcare funding and weak supply chain systems, continues to limit consistent implementation of guideline-compliant testing and undermines efforts to significantly reduce TB incidence.

Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%. APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.

This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Diagnostics.

The Tuberculosis (TB) Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tuberculosis (TB) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others

Segment by Application

Diagnostic Laboratories
Hospitals

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tuberculosis (TB) Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Culture-Based Diagnostics

1.2.3 Sputum Smear Microscopy

1.2.4 Rapid Molecular Diagnostics

1.2.5 Others

1.3 Market by Application

1.3.1 Global Tuberculosis (TB) Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Diagnostic Laboratories

1.3.3 Hospitals

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2020-2031)

2.2 Global Tuberculosis (TB) Diagnostics Growth Trends by Region

2.2.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Tuberculosis (TB) Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Tuberculosis (TB) Diagnostics Market Dynamics

2.3.1 Tuberculosis (TB) Diagnostics Industry Trends

2.3.2 Tuberculosis (TB) Diagnostics Market Drivers

2.3.3 Tuberculosis (TB) Diagnostics Market Challenges

2.3.4 Tuberculosis (TB) Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue

3.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Top Tuberculosis (TB) Diagnostics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Tuberculosis (TB) Diagnostics Revenue

3.4 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio

3.4.1 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Diagnostics Revenue in 2024

3.5 Global Key Players of Tuberculosis (TB) Diagnostics Head office and Area Served

3.6 Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application

3.7 Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tuberculosis (TB) Diagnostics Breakdown Data by Type

4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031)

5 Tuberculosis (TB) Diagnostics Breakdown Data by Application

5.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Tuberculosis (TB) Diagnostics Market Size (2020-2031)

6.2 North America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)

6.4 North America Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tuberculosis (TB) Diagnostics Market Size (2020-2031)

7.2 Europe Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)

7.4 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Tuberculosis (TB) Diagnostics Market Size (2020-2031)

9.2 Latin America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Danaher

11.1.1 Danaher Company Details

11.1.2 Danaher Business Overview

11.1.3 Danaher Tuberculosis (TB) Diagnostics Introduction

11.1.4 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.1.5 Danaher Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Tuberculosis (TB) Diagnostics Introduction

11.2.4 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Introduction

11.3.4 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 BD

11.4.1 BD Company Details

11.4.2 BD Business Overview

11.4.3 BD Tuberculosis (TB) Diagnostics Introduction

11.4.4 BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.4.5 BD Recent Development

11.5 Abbott

11.5.1 Abbott Company Details

11.5.2 Abbott Business Overview

11.5.3 Abbott Tuberculosis (TB) Diagnostics Introduction

11.5.4 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.5.5 Abbott Recent Development

11.6 Hologic

11.6.1 Hologic Company Details

11.6.2 Hologic Business Overview

11.6.3 Hologic Tuberculosis (TB) Diagnostics Introduction

11.6.4 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.6.5 Hologic Recent Development

11.7 Qiagen

11.7.1 Qiagen Company Details

11.7.2 Qiagen Business Overview

11.7.3 Qiagen Tuberculosis (TB) Diagnostics Introduction

11.7.4 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.7.5 Qiagen Recent Development

11.8 BioMerieux

11.8.1 BioMerieux Company Details

11.8.2 BioMerieux Business Overview

11.8.3 BioMerieux Tuberculosis (TB) Diagnostics Introduction

11.8.4 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.8.5 BioMerieux Recent Development

11.9 Hain Lifescience

11.9.1 Hain Lifescience Company Details

11.9.2 Hain Lifescience Business Overview

11.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Introduction

11.9.4 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.9.5 Hain Lifescience Recent Development

11.10 Oxford Immunotec

11.10.1 Oxford Immunotec Company Details

11.10.2 Oxford Immunotec Business Overview

11.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Introduction

11.10.4 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.10.5 Oxford Immunotec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Culture-Based Diagnostics

Table 3. Key Players of Sputum Smear Microscopy

Table 4. Key Players of Rapid Molecular Diagnostics

Table 5. Key Players of Others

Table 6. Global Tuberculosis (TB) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Tuberculosis (TB) Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Tuberculosis (TB) Diagnostics Market Share by Region (2020-2025)

Table 10. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Tuberculosis (TB) Diagnostics Market Share by Region (2026-2031)

Table 12. Tuberculosis (TB) Diagnostics Market Trends

Table 13. Tuberculosis (TB) Diagnostics Market Drivers

Table 14. Tuberculosis (TB) Diagnostics Market Challenges

Table 15. Tuberculosis (TB) Diagnostics Market Restraints

Table 16. Global Tuberculosis (TB) Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Tuberculosis (TB) Diagnostics Market Share by Players (2020-2025)

Table 18. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)

Table 19. Ranking of Global Top Tuberculosis (TB) Diagnostics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Tuberculosis (TB) Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Tuberculosis (TB) Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application

Table 23. Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)

Table 27. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2026-2031)

Table 29. Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)

Table 31. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2026-2031)

Table 33. North America Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Danaher Company Details

Table 49. Danaher Business Overview

Table 50. Danaher Tuberculosis (TB) Diagnostics Product

Table 51. Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 52. Danaher Recent Development

Table 53. Roche Company Details

Table 54. Roche Business Overview

Table 55. Roche Tuberculosis (TB) Diagnostics Product

Table 56. Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 57. Roche Recent Development

Table 58. Thermo Fisher Scientific Company Details

Table 59. Thermo Fisher Scientific Business Overview

Table 60. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product

Table 61. Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 62. Thermo Fisher Scientific Recent Development

Table 63. BD Company Details

Table 64. BD Business Overview

Table 65. BD Tuberculosis (TB) Diagnostics Product

Table 66. BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 67. BD Recent Development

Table 68. Abbott Company Details

Table 69. Abbott Business Overview

Table 70. Abbott Tuberculosis (TB) Diagnostics Product

Table 71. Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 72. Abbott Recent Development

Table 73. Hologic Company Details

Table 74. Hologic Business Overview

Table 75. Hologic Tuberculosis (TB) Diagnostics Product

Table 76. Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 77. Hologic Recent Development

Table 78. Qiagen Company Details

Table 79. Qiagen Business Overview

Table 80. Qiagen Tuberculosis (TB) Diagnostics Product

Table 81. Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 82. Qiagen Recent Development

Table 83. BioMerieux Company Details

Table 84. BioMerieux Business Overview

Table 85. BioMerieux Tuberculosis (TB) Diagnostics Product

Table 86. BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 87. BioMerieux Recent Development

Table 88. Hain Lifescience Company Details

Table 89. Hain Lifescience Business Overview

Table 90. Hain Lifescience Tuberculosis (TB) Diagnostics Product

Table 91. Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 92. Hain Lifescience Recent Development

Table 93. Oxford Immunotec Company Details

Table 94. Oxford Immunotec Business Overview

Table 95. Oxford Immunotec Tuberculosis (TB) Diagnostics Product

Table 96. Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 97. Oxford Immunotec Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Tuberculosis (TB) Diagnostics Picture

Figure 2. Global Tuberculosis (TB) Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Tuberculosis (TB) Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. Culture-Based Diagnostics Features

Figure 5. Sputum Smear Microscopy Features

Figure 6. Rapid Molecular Diagnostics Features

Figure 7. Others Features

Figure 8. Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Tuberculosis (TB) Diagnostics Market Share by Application: 2024 VS 2031

Figure 10. Diagnostic Laboratories Case Studies

Figure 11. Hospitals Case Studies

Figure 12. Tuberculosis (TB) Diagnostics Report Years Considered

Figure 13. Global Tuberculosis (TB) Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Tuberculosis (TB) Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Tuberculosis (TB) Diagnostics Market Share by Region: 2024 VS 2031

Figure 16. Global Tuberculosis (TB) Diagnostics Market Share by Players in 2024

Figure 17. Global Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Diagnostics Revenue in 2024

Figure 19. North America Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)

Figure 21. United States Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)

Figure 25. Germany Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Ireland Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Tuberculosis (TB) Diagnostics Market Share by Region (2020-2031)

Figure 33. China Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia & New Zealand Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)

Figure 41. Mexico Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)

Figure 45. Israel Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Danaher Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 49. Roche Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 51. BD Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 52. Abbott Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 53. Hologic Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 54. Qiagen Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 55. BioMerieux Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 56. Hain Lifescience Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 57. Oxford Immunotec Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Tuberculosis (TB) Diagnostics market? zhanKai

The top companies in the global Tuberculosis (TB) Diagnostics market are Danaher、Roche、Thermo Fisher Scientific.

Which region is expected to have the highest market share? shouQi

What was the global market size of Tuberculosis (TB) Diagnostics in 2031? shouQi

What was the global market size of Tuberculosis (TB) Diagnostics in 2025? shouQi

What is the annual compound growth rate of the global Tuberculosis (TB) Diagnostics market size from 2025 to 2031? shouQi

Related Reports

Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Tuberculosis (TB) Diagnostics market size was US$ 3186 million in 2025 and is forecast to reach a readjusted size of US$ 4318 million by 2032 with a CAGR of 4.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 76
USD 4250.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Research Report 2026
The global Tuberculosis (TB) Diagnostics market was valued at US$ 3186 million in 2025 and is anticipated to reach US$ 4318 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 2900.00
(Single User License)
Tuberculosis (TB) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 3186 million in 2025 and is projected to reach US$ 4318 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 88
USD 3950.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ 3070 million in 2024 to US$ 4149 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 126
USD 4900.00
(Single User License)
Tuberculosis (TB) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 3070 million in 2024 and is forecast to a readjusted size of US$ 4149 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-06-22
Pages: 98
USD 3950.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Insights, Forecast to 2031
The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ 3186 million in 2025 to US$ 4149 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.
Published Date: 2025-06-22
Pages: 121
USD 4900.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tuberculosis (TB) Diagnostics market size was US$ 3070 million in 2024 and is forecast to a readjusted size of US$ 4149 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-06-22
Pages: 76
USD 4250.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million and is forecast to reach approximately US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 128
USD 5900.00
(Single User License)
Tuberculosis (TB) Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million in 2024 and is forecast to a readjusted size of US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 94
USD 3950.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Published Date: 2024-04-17
Pages: 153
USD 5600.00
(Single User License)

Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Tuberculosis (TB) Diagnostics market size was US$ 3186 million in 2025 and is forecast to reach a readjusted size of US$ 4318 million by 2032 with a CAGR of 4.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 76
USD 4250.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Research Report 2026
The global Tuberculosis (TB) Diagnostics market was valued at US$ 3186 million in 2025 and is anticipated to reach US$ 4318 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
USD 2900.00 (Single User License)
Tuberculosis (TB) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 3186 million in 2025 and is projected to reach US$ 4318 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 88
USD 3950.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ 3070 million in 2024 to US$ 4149 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 126
USD 4900.00 (Single User License)
Tuberculosis (TB) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 3070 million in 2024 and is forecast to a readjusted size of US$ 4149 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-06-22
Pages: 98
USD 3950.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Insights, Forecast to 2031
The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ 3186 million in 2025 to US$ 4149 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.
Published: 2025-06-22
Pages: 121
USD 4900.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tuberculosis (TB) Diagnostics market size was US$ 3070 million in 2024 and is forecast to a readjusted size of US$ 4149 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-06-22
Pages: 76
USD 4250.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million and is forecast to reach approximately US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 128
USD 5900.00 (Single User License)
Tuberculosis (TB) Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million in 2024 and is forecast to a readjusted size of US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 94
USD 3950.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Published: 2024-04-17
Pages: 153
USD 5600.00 (Single User License)